Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RGC-32 facilitates pancreatic cancer via activating Wnt/β-catenin signaling.

Cellular and molecular biology (Noisy-le-Grand, France) - 20 Dec 2023

He Jinli, Yang Guihong, Cao Ronglai, Zhu Liang

Abstract excerpt

Longitudinal studies have indicated the facilitating effect of RGC-32 during diverse disease progression including pancreatic cancer, yet the systematic and detailed effect of RGC-32 during pancreatic cancer is largely unknowable. For this purpose, we took advantage of the pancreatic cancer cell line (BXPC3) with RGC-32 expression and then modulated its expression by lentivirus-mediated knockdown (shRGC-32) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Cell Cycle
Share to Cell Movement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Gene Expression Regulation, Neoplastic

Share to Nuclear Proteins

Share to Pancreatic Neoplasms

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 38279451
DOI: 10.14715/cmb/2023.69.14.26

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RGC-32 facilitates pancreatic cancer via activating Wnt/β-catenin signaling.PMID 38279451Read ↗

Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3.Semantic proximity Read ↗

DDX31: A Novel Functional Oncogene Promotes Migration and Proliferation of Pancreatic CancerSemantic proximity Read ↗

RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC.Semantic proximity Read ↗

Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.Semantic proximity Read ↗

Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.Semantic proximity Read ↗

Targeting glypican‐4 overcomes 5‐FU resistance and attenuates stem cell–like properties via suppression of Wnt/β‐catenin pathway in pancreatic cancer cellsSemantic proximity Read ↗

Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathwaySemantic proximity Read ↗

CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling PathwaySemantic proximity Read ↗

GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathwaySemantic proximity Read ↗

STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR PathwaySemantic proximity Read ↗

Deciphering role of FGFR signalling pathway in pancreatic cancerSemantic proximity Read ↗

TRIM37 promoted the growth and migration of the pancreatic cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.